Accueil   Appels à projets   H2020 Health - calls 2020 - 1.3 Infectious diseases (PCP - PPI)

H2020 Health – calls 2020 – 1.3 Infectious diseases (PCP – PPI)

Call 1 - better health and care
1.3 Infectious diseases (PCP - PPI)

Les grandes lignes de l'appel à projets

Type de l'appel : Collaboratif

Date d'ouverture : 25 Juin 2019

Date de clôture : 7 Avril 2020

Dimension : Europe

Financement :

Thématique(s) médicale(s) : Toutes thématiques

Secteur(s) industriel(s) :

SC1-BHC-20A-2020: Pre-commercial procurement (PCP) for integrated care solutions

Scope: PCP actions targeting consortia of procurers with similar procurement needs that want to procure together the development of innovative integrated care solutions to modernize public services whilst creating growth opportunities for industry and researchers in Europe in addition to new markets. These can include, but are not limited to formal or informal organisational solutions, personal-health and self-care solutions, professional care solutions and ICT-based solutions. This topic is open to proposals for PCP actions in all areas of public sector interest requiring innovative integrated care solutions. It is open both to proposals requiring improvements mainly based on one specific solution/technology field, as well as to proposals requiring end-to-end solutions that need combinations of different innovative solutions from the healthcare point of view.

SC1-BHC-20B-2020: Public procurement of innovative solutions (PPI) for diagnostics for infectious diseases

Scope: This topic will contribute to the EU One Health Action Plan on Antimicrobial
Resistance and should specifically consider the following:
– Development of proposals for ‘Public Procurement of Innovative Solutions’ for the
implementation of rapid diagnostic tools for infectious diseases in clinical practice.
Proposals should be driven by clearly identified procurement needs of the participating
organisations. In order to ensure compatibility and interoperability between infectious
disease diagnostics and avoid technical/technology standardisation issues, public health
procurers should also develop specifications that are applicable for EU-wide deployment
of the innovative diagnostics.
– Applications should be driven by public and/or private procurers from each participating
country (at national, regional or local level) that have responsibilities and budget control
in the relevant area of supply of health and care services. They should demonstrate the
applicability of the ‘Most Economically Advantageous Tendering’ approach in crossborder
collaboration of public procurers in the EU, defining specific outcome criteria of
importance for patients well-being, and for innovation of public procurement in the area
of infectious diseases and AMR, taking also into account overall economic and societal
benefits, and sex and gender differences when relevant..

En poursuivant votre navigation sur notre site, vous acceptez l'utilisation des cookies et la collecte de vos données et informations personnelles par Lyonbiopôle, dans les finalités de mesurer le trafic sur le site Web, de fournir des statistiques et de vous proposer des contenus adaptés à vos centres d’intérets. Pour exercer vos droits d'accès, de rectification, d'opposition, de suppression et de portabilité, conformément au règlement général sur la protection des données (UE n°2016/679), vous etes informés que vous pouvez envoyer votre demande à dpo@lyonbiopole.com. Plus de détails sont disponibles en cliquant ici J'accepte